Langerhans cells: An update;Langerhans-Zellen: ein Update

JDDG - Journal of the German Society of Dermatology

Volumn 12, Issue 12, 2014, Pages 1107-1111

  Sparber, Florian ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; FLT3 LIGAND; GLYCOPROTEIN P 15095; LANGERIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOGENIC PROTEIN 1; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 5; TRANSFORMING GROWTH FACTOR BETA1;

ANTIGEN EXPRESSION; AUTOIMMUNITY; BACTERIAL INFECTION; CELL POPULATION; CONTACT ALLERGY; CYTOKINE PRODUCTION; DERMATITIS; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LANGERHANS CELL; NONHUMAN; REVIEW; STAPHYLOCOCCAL SCALDED SKIN SYNDROME; VIRAL SKIN DISEASE; ANTIGEN PRESENTATION; CELL SUBPOPULATION; EPITHELIUM; FAMILY; MAMMAL; ONTOGENY; PREVENTION; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; IMMUNOLOGY; INNATE IMMUNITY; SKIN;

ANIMALS; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; LANGERHANS CELLS; MODELS, IMMUNOLOGICAL; SKIN;

EID: 84915757178     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/ddg.12506     Document Type: Review

References (43)

1. Schuler G, Steinman RM,. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 1985; 161: 526-46.
2. Merad M, Sathe P, Helft J, et al. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 2013; 31: 563-604.
3. Romani N, Clausen BE, Stoitzner P,. Langerhans Cells & More: Langerin-expressing dendritic cell subsets in the skin. Immunol Rev 2010; 234: 120-41.
4. Hoeffel G, Wang Y, Greter M, et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J Exp Med 2012; 209: 1167-81.
5. Chorro L, Sarde A, Li M, et al. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J Exp Med 2009; 206: 3089-100.
6. Merad M, Manz MG, Karsunky H, et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 2002; 3: 1135-41.
7. Merad M, Hoffmann P, Ranheim E, et al. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med 2004; 10: 510-7.
8. Ghigo C, Mondor I, Jorquera A, et al. Multicolor fate mapping of Langerhans cell homeostasis. J Exp Med 2013, 210: 1657-64.
9. Nagao K, Kobayashi T, Moro K, et al. Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin. Nat Immunol 2012; 13: 744-52.
10. Seré K, Baek JH, Ober-Blöbaum J, et al. Two distinct types of Langerhans cells populate the skin during steady state and inflammation. Immunity 2012; 37: 905-16.
11. Vishwanath M, Nishibu A, Saeland S, et al. Development of intravital intermittent confocal imaging system for studying Langerhans cell turnover. J Invest Dermatol 2006; 126: 2452-7.
12. Krueger GG, Daynes RA, Emam M,. Biology of Langerhans cells: selective migration of Langerhans cells into allogeneic and xenogeneic grafts on nude mice. PNAS 1983; 80: 1650-4.
13. Kanitakis J, Petruzzo P, Dubernard JM,. Turnover of epidermal Langerhans cells. N Engl. J Med 2004; 351: 2661-2.
14. Iram N, Mildner M, Prior M, et al. Age-related changes in expression and function of Toll-like receptors in human skin. Development 2012; 139: 4210-9.
15. Gilchrest BA, Murphy GF, Soter NA,. Effect of chronologic aging and ultraviolet irradiation on Langerhans cells in human epidermis. J Invest Dermatol 1982; 79: 85-8.
16. Bhushan M, Cumberbatch M, Dearman RJ, et al. Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br J Dermatol 2002; 146: 32-40.
17. Ogden S, Dearman RJ, Kimber I, Griffiths CEM,. The effect of ageing on phenotype and function of monocyte-derived Langerhans cells. Br J Dermatol 2011; 165: 184-8.
18. Xu YP, Qi RQ, Chen W, et al. Aging affects epidermal Langerhans cell development and function and alters their miRNA gene expression profile. Aging (Albany NY) 2012; 4: 742-54.
19. Chang AL, Atzmon G, Bergman A, et al. Identification of genes promoting skin youthfulness by genome-wide association study. J Invest Dermatol 2014; 134: 651-7.
20. Brasel K, De Smedt T, Smith JL, Maliszewski CR,. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 2000; 96: 3029-39.
21. McKenna HJ, Stocking KL, Miller RE, et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000; 95: 3489-97.
22. Waskow C, Liu K, Darrasse-Jeze G, et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol 2008; 9: 676-83.
23. Borkowski TA, Letterio JJ, Farr AG, Udey MC,. A role for endogenous transforming growth factor ß1 in Langerhans cell biology: The skin of transforming growth factor ß1 null mice is devoid of epidermal Langerhans cells. J Exp Med 1996; 184: 2417-22.
24. Kaplan DH, Li MO, Jenison MC, et al. Autocrine/paracrine TGFß1 is required for the development of epidermal Langerhans cells. J Exp Med 2007; 204: 2545-52.
25. Kel JM, Girard-Madoux MJH, Reizis B, Clausen BE,. TGF-ß is required to maintain the pool of immature Langerhans cells in the epidermis. J Immunol 2010; 185: 3248-55.
26. Chopin M, Seillet C, Chevrier S, et al. Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks. J Exp Med 2014; 210: 2967-80.
27. Fainaru O, Woolf E, Lotem J, et al. Runx3 regulates mouse TGF-ß-mediated dendritic cell function and its absence results in airway inflammation. EMBO J 2004; 23: 969-79.
28. Hacker C, Kirsch RD, Ju XS, et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol 2003; 4: 380-6.
29. Yasmin N, Bauer T, Modak M, et al. Identification of bone morphogenetic protein 7 (BMP7) as an instructive factor for human epidermal Langerhans cell differentiation. J Exp Med 2013; 210: 2597-610.
30. Ginhoux F, Tacke F, Angeli V, et al. Langerhans cells arise from monocytes in vivo. Nat Immunol 2006; 7: 265-73.
31. Greter M, Lelios I, Pelczar P, et al. Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity 2012; 37: 1050-60.
32. Wang Y, Szretter KJ, Vermi W, et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 2012; 13: 753-60.
33. Kellersch B, Brocker T,. Langerhans cell homeostasis in mice is dependent on mTORC1 but not mTORC2 function. Blood 2013; 121: 298-307.
34. Sparber F, Scheffler JM, Amberg N, et al. The late endosomal adaptor molecule p14 (LAMTOR2) represents a novel regulator of Langerhans cell homeostasis. Blood 2014; 123: 217-27.
35. Sparber F, Tripp CH, Komenda K, et al. The late endosomal adaptor molecule p14 (LAMTOR2) regulates TGFß1-mediated homeostasis of Langerhans cells. J Invest Dermatol 2014; doi: 10.1038/jid.2014.324. [Epub ahead of print].
36. Becker MR, Choi YS, Millar SE, Udey MC,. Wnt signaling influences the development of murine epidermal langerhans cells. J Invest Dermatol 2011; 131: 1861-8.
37. Noordegraaf M, Flacher V, Stoitzner P, Clausen BE,. Functional redundancy of Langerhans cells and Langerin+ dermal dendritic cells in contact hypersensitivity. J Invest Dermatol 2010; 130: 2752-9.
38. Kaplan DH, Jenison MC, Saeland S, et al. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005; 23: 611-20.
39. Ouchi T, Kubo A, Yokouchi M, et al. Langerhans cell antigen capture through tight junctions confers preemptive immunity in experimental staphylococcal scalded skin syndrome. J Exp Med 2011; 208: 2607-13.
40. Kautz-Neu K, Noordegraaf M, Dinges S, et al. Langerhans cells are negative regulators of the anti-Leishmania response. J Exp Med 2011; 208: 885-91.
41. Shibaki A, Sato A, Vogel JC, et al. Induction of GVHD-like skin disease by passively transferred T cell receptor transgenic CD8+ T cells into keratin-14-ovalbumin transgenic mice. J Invest Dermatol 2004; 123: 109-15.
42. Waithman J, Allan RS, Kosaka H, et al. Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells. J Immunol 2007; 179: 4535-41.
43. Seneschal J, Clark RA, Gehad A, et al. Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 2012; 36: 873-84.